EMEA (Europe, Middle East and Africa) Liraglutide Injection Market Report 2018

March 2018 | 109 pages | ID: E60A3447417EN
QYResearch

Abstracts

In this report, the EMEA Liraglutide Injection market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Liraglutide Injection for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Liraglutide Injection market competition by top manufacturers/players, with Liraglutide Injection sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novo Nordisk

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Type I
• Type II

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hypoglycemic
• Weight Lose
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Liraglutide Injection Market Report 2018

1 LIRAGLUTIDE INJECTION OVERVIEW

1.1 Product Overview and Scope of Liraglutide Injection
1.2 Classification of Liraglutide Injection
  1.2.1 EMEA Liraglutide Injection Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Liraglutide Injection Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3
  1.2.4
1.3 EMEA Liraglutide Injection Market by Application/End Users
  1.3.1 EMEA Liraglutide Injection Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hypoglycemic
  1.3.3 Weight Lose
  1.3.4 Others
1.4 EMEA Liraglutide Injection Market by Region
  1.4.1 EMEA Liraglutide Injection Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Liraglutide Injection (2013-2025)
  1.5.1 EMEA Liraglutide Injection Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Liraglutide Injection Revenue and Growth Rate (2013-2025)

2 EMEA LIRAGLUTIDE INJECTION COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Liraglutide Injection Market Competition by Players/Manufacturers
  2.1.1 EMEA Liraglutide Injection Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Liraglutide Injection Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Liraglutide Injection Sale Price by Players (2013-2018)
2.2 EMEA Liraglutide Injection (Volume and Value) by Type/Product Category
  2.2.1 EMEA Liraglutide Injection Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Liraglutide Injection Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Liraglutide Injection Sale Price by Type (2013-2018)
2.3 EMEA Liraglutide Injection (Volume) by Application
2.4 EMEA Liraglutide Injection (Volume and Value) by Region
  2.4.1 EMEA Liraglutide Injection Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Liraglutide Injection Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Liraglutide Injection Sales Price by Region (2013-2018)

3 EUROPE LIRAGLUTIDE INJECTION (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Liraglutide Injection Sales and Value (2013-2018)
  3.1.1 Europe Liraglutide Injection Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Liraglutide Injection Revenue and Growth Rate (2013-2018)
3.2 Europe Liraglutide Injection Sales and Market Share by Type
3.3 Europe Liraglutide Injection Sales and Market Share by Application
3.4 Europe Liraglutide Injection Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Liraglutide Injection Sales Volume by Countries (2013-2018)
  3.4.2 Europe Liraglutide Injection Revenue by Countries (2013-2018)
  3.4.3 Germany Liraglutide Injection Sales and Growth Rate (2013-2018)
  3.4.4 France Liraglutide Injection Sales and Growth Rate (2013-2018)
  3.4.5 UK Liraglutide Injection Sales and Growth Rate (2013-2018)
  3.4.6 Russia Liraglutide Injection Sales and Growth Rate (2013-2018)
  3.4.7 Italy Liraglutide Injection Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Liraglutide Injection Sales and Growth Rate (2013-2018)

4 MIDDLE EAST LIRAGLUTIDE INJECTION (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Liraglutide Injection Sales and Value (2013-2018)
  4.1.1 Middle East Liraglutide Injection Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Liraglutide Injection Revenue and Growth Rate (2013-2018)
4.2 Middle East Liraglutide Injection Sales and Market Share by Type
4.3 Middle East Liraglutide Injection Sales and Market Share by Application
4.4 Middle East Liraglutide Injection Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Liraglutide Injection Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Liraglutide Injection Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Liraglutide Injection Sales and Growth Rate (2013-2018)
  4.4.4 Israel Liraglutide Injection Sales and Growth Rate (2013-2018)
  4.4.5 UAE Liraglutide Injection Sales and Growth Rate (2013-2018)
  4.4.6 Iran Liraglutide Injection Sales and Growth Rate (2013-2018)

5 AFRICA LIRAGLUTIDE INJECTION (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Liraglutide Injection Sales and Value (2013-2018)
  5.1.1 Africa Liraglutide Injection Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Liraglutide Injection Revenue and Growth Rate (2013-2018)
5.2 Africa Liraglutide Injection Sales and Market Share by Type
5.3 Africa Liraglutide Injection Sales and Market Share by Application
5.4 Africa Liraglutide Injection Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Liraglutide Injection Sales Volume by Countries (2013-2018)
  5.4.2 Africa Liraglutide Injection Revenue by Countries (2013-2018)
  5.4.3 South Africa Liraglutide Injection Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Liraglutide Injection Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Liraglutide Injection Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Liraglutide Injection Sales and Growth Rate (2013-2018)

6 EMEA LIRAGLUTIDE INJECTION MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Novo Nordisk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Liraglutide Injection Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novo Nordisk Liraglutide Injection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview

7 LIRAGLUTIDE INJECTION MANUFACTURING COST ANALYSIS

7.1 Liraglutide Injection Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Liraglutide Injection

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Liraglutide Injection Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Liraglutide Injection Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA LIRAGLUTIDE INJECTION MARKET FORECAST (2018-2025)

11.1 EMEA Liraglutide Injection Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Liraglutide Injection Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Liraglutide Injection Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Liraglutide Injection Price and Trend Forecast (2018-2025)
11.2 EMEA Liraglutide Injection Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Liraglutide Injection Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Liraglutide Injection Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Liraglutide Injection Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Liraglutide Injection Sales Forecast by Type (2018-2025)
11.7 EMEA Liraglutide Injection Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Liraglutide Injection
Figure EMEA Liraglutide Injection Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Liraglutide Injection Sales Volume Market Share by Type (Product Category) in 2017
Figure Type I Product Picture
Figure Type II Product Picture
Figure EMEA Liraglutide Injection Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Liraglutide Injection by Application in 2017
Figure Hypoglycemic Examples
Table Key Downstream Customer in Hypoglycemic
Figure Weight Lose Examples
Table Key Downstream Customer in Weight Lose
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Liraglutide Injection Market Size (Million USD) by Region (2013-2025)
Figure Europe Liraglutide Injection Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Liraglutide Injection Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Liraglutide Injection Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Liraglutide Injection Revenue (Million USD) Status and Forecast by Countries
Figure Africa Liraglutide Injection Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Liraglutide Injection Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Liraglutide Injection Sales Volume and Growth Rate (2013-2025)
Figure EMEA Liraglutide Injection Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Liraglutide Injection Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Liraglutide Injection Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Liraglutide Injection Sales Share by Players (2013-2018)
Figure 2017 Liraglutide Injection Sales Share by Players
Figure 2017 Liraglutide Injection Sales Share by Players
Figure EMEA Liraglutide Injection Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Liraglutide Injection Revenue (Million USD) by Players (2013-2018)
Table EMEA Liraglutide Injection Revenue Share by Players (2013-2018)
Table 2017 EMEA Liraglutide Injection Revenue Share by Players
Table 2017 EMEA Liraglutide Injection Revenue Share by Players
Table EMEA Liraglutide Injection Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Liraglutide Injection Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Liraglutide Injection Sales Share by Type (2013-2018)
Figure Sales Market Share of Liraglutide Injection by Type (2013-2018)
Figure EMEA Liraglutide Injection Sales Market Share by Type (2013-2018)
Table EMEA Liraglutide Injection Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Liraglutide Injection Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Liraglutide Injection by Type in 2017
Table EMEA Liraglutide Injection Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Liraglutide Injection Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Liraglutide Injection Sales Share by Application (2013-2018)
Figure Sales Market Share of Liraglutide Injection by Application (2013-2018)
Figure EMEA Liraglutide Injection Sales Market Share by Application in 2017
Table EMEA Liraglutide Injection Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Liraglutide Injection Sales Share by Region (2013-2018)
Figure Sales Market Share of Liraglutide Injection by Region (2013-2018)
Figure EMEA Liraglutide Injection Sales Market Share in 2017
Table EMEA Liraglutide Injection Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Liraglutide Injection Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Liraglutide Injection by Region (2013-2018)
Figure EMEA Liraglutide Injection Revenue Market Share Regions in 2017
Table EMEA Liraglutide Injection Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Liraglutide Injection Revenue and Growth Rate (2013-2018)
Table Europe Liraglutide Injection Sales (K Units) by Type (2013-2018)
Table Europe Liraglutide Injection Market Share by Type (2013-2018)
Figure Europe Liraglutide Injection Market Share by Type in 2017
Table Europe Liraglutide Injection Sales (K Units) by Application (2013-2018)
Table Europe Liraglutide Injection Market Share by Application (2013-2018)
Figure Europe Liraglutide Injection Market Share by Application in 2017
Table Europe Liraglutide Injection Sales (K Units) by Countries (2013-2018)
Table Europe Liraglutide Injection Sales Market Share by Countries (2013-2018)
Figure Europe Liraglutide Injection Sales Market Share by Countries (2013-2018)
Figure Europe Liraglutide Injection Sales Market Share by Countries in 2017
Table Europe Liraglutide Injection Revenue (Million USD) by Countries (2013-2018)
Table Europe Liraglutide Injection Revenue Market Share by Countries (2013-2018)
Figure Europe Liraglutide Injection Revenue Market Share by Countries (2013-2018)
Figure Europe Liraglutide Injection Revenue Market Share by Countries in 2017
Figure Germany Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure France Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure UK Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Liraglutide Injection Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Liraglutide Injection Sales (K Units) by Type (2013-2018)
Table Middle East Liraglutide Injection Market Share by Type (2013-2018)
Figure Middle East Liraglutide Injection Market Share by Type (2013-2018)
Table Middle East Liraglutide Injection Sales (K Units) by Applications (2013-2018)
Table Middle East Liraglutide Injection Market Share by Applications (2013-2018)
Figure Middle East Liraglutide Injection Sales Market Share by Application in 2017
Table Middle East Liraglutide Injection Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Liraglutide Injection Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Liraglutide Injection Sales Volume Market Share by Countries in 2017
Table Middle East Liraglutide Injection Revenue (Million USD) by Countries (2013-2018)
Table Middle East Liraglutide Injection Revenue Market Share by Countries (2013-2018)
Figure Middle East Liraglutide Injection Revenue Market Share by Countries (2013-2018)
Figure Middle East Liraglutide Injection Revenue Market Share by Countries in 2017
Figure Saudi Arabia Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Liraglutide Injection Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Liraglutide Injection Sales (K Units) by Type (2013-2018)
Table Africa Liraglutide Injection Sales Market Share by Type (2013-2018)
Figure Africa Liraglutide Injection Sales Market Share by Type (2013-2018)
Figure Africa Liraglutide Injection Sales Market Share by Type in 2017
Table Africa Liraglutide Injection Sales (K Units) by Application (2013-2018)
Table Africa Liraglutide Injection Sales Market Share by Application (2013-2018)
Figure Africa Liraglutide Injection Sales Market Share by Application (2013-2018)
Table Africa Liraglutide Injection Sales Volume (K Units) by Countries (2013-2018)
Table Africa Liraglutide Injection Sales Market Share by Countries (2013-2018)
Figure Africa Liraglutide Injection Sales Market Share by Countries (2013-2018)
Figure Africa Liraglutide Injection Sales Market Share by Countries in 2017
Table Africa Liraglutide Injection Revenue (Million USD) by Countries (2013-2018)
Table Africa Liraglutide Injection Revenue Market Share by Countries (2013-2018)
Figure Africa Liraglutide Injection Revenue Market Share by Countries (2013-2018)
Figure Africa Liraglutide Injection Revenue Market Share by Countries in 2017
Figure South Africa Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Table Novo Nordisk Liraglutide Injection Basic Information List
Table Novo Nordisk Liraglutide Injection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Liraglutide Injection Sales (K Units) and Growth Rate (2013-2018)
Figure Novo Nordisk Liraglutide Injection Sales Market Share in EMEA (2013-2018)
Figure Novo Nordisk Liraglutide Injection Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Liraglutide Injection
Figure Manufacturing Process Analysis of Liraglutide Injection
Figure Liraglutide Injection Industrial Chain Analysis
Table Raw Materials Sources of Liraglutide Injection Major Manufacturers in 2017
Table Major Buyers of Liraglutide Injection
Table Distributors/Traders List
Figure EMEA Liraglutide Injection Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Liraglutide Injection Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Liraglutide Injection Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Liraglutide Injection Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Liraglutide Injection Sales Market Share Forecast by Region (2018-2025)
Table EMEA Liraglutide Injection Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Liraglutide Injection Revenue Market Share Forecast by Region (2018-2025)
Table Europe Liraglutide Injection Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Liraglutide Injection Sales Market Share Forecast by Countries (2018-2025)
Table Europe Liraglutide Injection Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Liraglutide Injection Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Liraglutide Injection Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Liraglutide Injection Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Liraglutide Injection Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Liraglutide Injection Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Liraglutide Injection Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Liraglutide Injection Sales Market Share Forecast by Countries (2018-2025)
Table Africa Liraglutide Injection Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Liraglutide Injection Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Liraglutide Injection Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Liraglutide Injection Sales Market Share Forecast by Type (2018-2025)
Table EMEA Liraglutide Injection Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Liraglutide Injection Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources